Therefore, we hypothesized that deoxyshikonin inhibited viability and glycolysis, suppressing pyruvate kinase M2 via the Akt/mTOR pathway in acute myeloid leukemia cells. This evidence concerns the gene AKT1 and acute myeloid leukemia.